Drug Discovery Technology Alert. Utilizing Platelet-Rich Plasma as a Nuclear Cell Differentiation Technology Platform; Increasing Reprogramming Efficiency of Induced Pluripotent Stem Cells

USD 950

* Required Fields

USD 950

PAY BY INVOICE

Be the first to review this product

This issue profiles utilizing platelet-rich plasma as a nuclear cell differentiation technology platform, increasing reprogramming efficiency of induced pluripotent stem cells, and a drug for autoimmune uveitis that receives orphan drug designation in Europe.

Table of Contents

Drug Discovery Technology Alert. Utilizing Platelet-Rich Plasma as a Nuclear Cell Differentiation Technology Platform; Increasing Reprogramming Efficiency of Induced Pluripotent Stem CellsIn This Issue1. BREAKTHROUGH IN PSORIASIS TREATMENT WITH APPROVAL OF SECUKINUMAB IN JAPAN2. DRUG FOR AUTOIMMUNE UVEITIS RECEIVES ORPHAN DRUG DESIGNATION IN EUROPE3. NOVEL DRUG THERAPY TO REDUCE CARDIAC STROKES ASSOCIATED WITH PERIPHERAL ARTERY DISEASE4. FDA-APPROVED DRUG TO TREAT ACUTE BACTERIAL SKIN INFECTION5. UTILIZING PLATELET-RICH PLASMA AS A NUCLEAR CELL DIFFERENTIATION TECHNOLOGY PLATFORM6. EX VIVO CELL REPROGRAMMING TO ADVANCE IN HEMATOPOIETIC CELLULAR THERAPEUTICS7. INCREASING REPROGRAMMING EFFICIENCY OF INDUCED PLURIPOTENT STEM CELLS8. PATENTS ON INDUCED PLURIPOTENT STEM CELLS




Related Research

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.